List view / Grid view


Abbott to acquire Veropharm

24 June 2014 | By Abbott

Abbott announced a definitive agreement to acquire Veropharm, a leading Russian pharmaceutical manufacturer...

Sanofi reports positive Phase 3 results for Toujeo®

19 June 2014 | By Sanofi

Sanofi announced that, in a pooled analysis, investigational therapy Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL) consistently showed significantly fewer low blood sugar events (hypoglycemia)...